Stocks to Watch on Dec 16, 2025: Tata Power, SBI, HCL Technologies & More in Focus

The Indian benchmark indices, Sensex and Nifty 50, are expected to begin Tuesday, December 16, on a subdued note, weighed down by weak cues from Asian markets following a decline in US equities on Friday.

Early indications from Gift Nifty also point to a muted opening, with the index trading around the 26,085 mark, down 5.5 points or 0.02% from the previous close of Nifty futures.

Tata Power

Tata Power said it plans to invest nearly ₹25,000 crore in capital expenditure during the current financial year and aims to maintain a similar annual investment pace through FY30, reinforcing its long-term growth and expansion strategy.

HCL Technologies

HCL Technologies announced the expansion of its digital transformation partnership with Aurobay Technologies to support the latter’s global growth. Under the engagement, HCLTech will manage SAP and Siemens Teamcenter PLM systems and provide integration services across Aurobay’s operations in Sweden and China.

State Bank of India (SBI)

State Bank of India stated that it will sign a €150-million line of credit agreement with Germany’s KfW on December 16. The funding will be used to support climate-friendly and sustainable energy projects.

Texmaco Rail

Texmaco Rail informed that it has secured an order valued at ₹132 crore from Touax Texmaco Railcar Leasing Pvt Ltd, its joint venture with the France-based Touax Group. The order is for the supply of railway rakes.

Delhivery

Delhivery announced the launch of an on-demand intracity delivery service via its Delhivery Direct app in Mumbai and Hyderabad. The new service allows customers to schedule parcel pickups within 15 minutes of placing a booking.

Hyundai Motor India

Hyundai Motor India said its shareholders have approved the appointment of Tarun Garg as Managing Director and Chief Executive Officer. His tenure in the new role will commence from January 1.

Senores Pharmaceuticals

Senores Pharmaceuticals disclosed that it has entered into a Share Purchase Agreement to acquire 100% stake in Apnar Pharma in two phases. Upon completion of the transaction, Apnar Pharma will function as a wholly owned subsidiary of Senores Pharmaceuticals.

Also Read: Wipro vs Infosys: Which IT Services Company Delivered Highest Earnings in Q2FY26?

Conclusion

Overall, domestic markets are likely to open cautiously amid weak global cues, while stock-specific developments such as large capex plans, strategic partnerships, funding tie-ups, new service launches, leadership changes, and acquisitions could drive selective action across sectors during the session.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.